<?xml version="1.0" encoding="UTF-8"?>
<status>
  <created_at>Fri Nov 06 16:39:24 +0000 2009</created_at>
  <id>5482684636</id>
  <text>European Strategy for Influenza A/H1N1 Vaccine Benefit-Risk Monitoring (EMEA) http://is.gd/4OXj8</text>
  <source>&lt;a href=&quot;http://www.chrisfinke.com/addons/twitterbar/&quot; rel=&quot;nofollow&quot;&gt;TwitterBar&lt;/a&gt;</source>
  <truncated>false</truncated>
  <in_reply_to_status_id></in_reply_to_status_id>
  <in_reply_to_user_id></in_reply_to_user_id>
  <favorited>false</favorited>
  <in_reply_to_screen_name></in_reply_to_screen_name>
  <user>
    <id>6647182</id>
    <name>Pierre Yves Arnoux</name>
    <screen_name>pierreyves</screen_name>
    <location>paris, france</location>
    <description>pharmacist into biotech, pharma, drug discovery, innovation, web 2.0, health 2.0, music and photography among other things</description>
    <profile_image_url>http://a1.twimg.com/profile_images/269891596/green_9928_3058918089_660b401a78_normal.jpg</profile_image_url>
    <url>http://biogeekblog.com/</url>
    <protected>false</protected>
    <followers_count>877</followers_count>
    <profile_background_color>352726</profile_background_color>
    <profile_text_color>3E4415</profile_text_color>
    <profile_link_color>D02B55</profile_link_color>
    <profile_sidebar_fill_color>99CC33</profile_sidebar_fill_color>
    <profile_sidebar_border_color>829D5E</profile_sidebar_border_color>
    <friends_count>632</friends_count>
    <created_at>Thu Jun 07 18:38:35 +0000 2007</created_at>
    <favourites_count>17</favourites_count>
    <utc_offset>3600</utc_offset>
    <time_zone>Paris</time_zone>
    <profile_background_image_url>http://a1.twimg.com/profile_background_images/57902330/IMG_3459.jpg</profile_background_image_url>
    <profile_background_tile>false</profile_background_tile>
    <notifications></notifications>
    <geo_enabled>false</geo_enabled>
    <verified>false</verified>
    <following></following>
    <statuses_count>2291</statuses_count>
  </user>
  <geo/>
</status>
